News
News
India takes first step towards universal health coverage with Digital Health Mission launch
The National Digital Health Mission, that Prime Minister Narendra Modi announced on Independence Day address, is envisioned as the first step towards Universal Health Coverage.
A digital health ecosystem will be put in place, complete with a personal health ID...
News
Trials begin for UK’s new coronavirus contact tracing app
Trials of a revamped NHS Test and Trace app have kicked off with residents on the Isle of Wight and NHS Volunteer Responders across England.
Tech giants Google and Apple worked with the NHS to develop the new app, after...
News
Nanobody-based antiviral developed at UCSF effectively blocks SARS-CoV-2 in the lab
Scientists at UCSF have engineered a new antibody-based antiviral for fighting the COVID-19 pandemic that can be administered as a nasal spray, providing a promising new avenue for slowing the spread of the virus. The potential therapy, dubbed AeroNabs,...
News
OPKO Health’s GeneDx Adds GenomeXpress to Its Industry-Leading Clinical Genomics Portfolio
GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company announced the launch of GenomeXpress, a rapid genome sequencing test. Verbal GenomeXpress results of pathogenic and/or likely pathogenic variants in known disease causing genes are delivered to...
News
Medtronic to Acquire Smart Insulin Pen Company Companion Medical
Medtronic plc, the global leader in medical technology, announced the planned acquisition of privately-held Companion Medical, manufacturer of InPen — the only U.S. FDA-cleared smart insulin pen system paired with an integrated diabetes management app on the market. The...
News
Multi-Vital Ambulatory Monitor for COVID-19 Patients Launches in the U.S.
VivaLink, a provider of connected healthcare solutions known for its unique medical wearable sensor platform, announced the availability of its new multi vital ambulatory monitoring solution for Infectious Respiratory Diseases. Currently deployed in Asia, Eastern Europe, and the Middle...
News
Thirty Madison Raises $47M in Series B Financing From Polaris Partners, J & J Innovation – JJDC, Inc. and Existing Investors
Thirty Madison, which operates three brands for hair loss, migraines and acid reflux, raised $47 million in a series B round. Polaris Partners led the round, and Johnson & Johnson participated as an investor.
With direct-to-consumer health brands Hims and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
